UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Advisor OS LLC

Advisor OS LLC lessened its position in UnitedHealth Group Incorporated (NYSE:UNH) by 4.4% during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 3,246 shares of the healthcare conglomerate’s stock after selling 149 shares during the period. Advisor OS LLC’s holdings in UnitedHealth Group were worth $1,653,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently bought and sold shares of UNH. Macroview Investment Management LLC grew its position in UnitedHealth Group by 671.4% in the 2nd quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock valued at $28,000 after buying an additional 47 shares in the last quarter. Delos Wealth Advisors LLC boosted its holdings in shares of UnitedHealth Group by 757.1% in the first quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock worth $30,000 after buying an additional 53 shares during the period. True Wealth Design LLC purchased a new stake in shares of UnitedHealth Group in the fourth quarter worth approximately $31,000. Bbjs Financial Advisors LLC purchased a new stake in shares of UnitedHealth Group in the second quarter worth approximately $31,000. Finally, Signature Resources Capital Management LLC raised its position in UnitedHealth Group by 40.0% during the second quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate’s stock valued at $32,000 after acquiring an additional 18 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

Insider Transactions at UnitedHealth Group

In other news, EVP Erin Mcsweeney sold 1,500 shares of the business’s stock in a transaction dated Thursday, July 18th. The stock was sold at an average price of $579.03, for a total transaction of $868,545.00. Following the completion of the transaction, the executive vice president now directly owns 7,785 shares in the company, valued at approximately $4,507,748.55. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. In related news, EVP Erin Mcsweeney sold 1,500 shares of the business’s stock in a transaction that occurred on Thursday, July 18th. The stock was sold at an average price of $579.03, for a total value of $868,545.00. Following the completion of the transaction, the executive vice president now directly owns 7,785 shares in the company, valued at approximately $4,507,748.55. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CAO Thomas E. Roos sold 2,851 shares of the business’s stock in a transaction that occurred on Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total value of $1,624,727.88. Following the completion of the transaction, the chief accounting officer now owns 29,501 shares of the company’s stock, valued at $16,812,029.88. The disclosure for this sale can be found here. Corporate insiders own 0.33% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts recently weighed in on UNH shares. Royal Bank of Canada raised their price objective on shares of UnitedHealth Group from $555.00 to $615.00 and gave the company an “outperform” rating in a research report on Wednesday, July 17th. JPMorgan Chase & Co. increased their price target on UnitedHealth Group from $546.00 to $559.00 and gave the company an “overweight” rating in a report on Thursday, May 30th. Robert W. Baird increased their price target on UnitedHealth Group from $597.00 to $640.00 and gave the company an “outperform” rating in a report on Wednesday, July 17th. StockNews.com upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Friday, August 30th. Finally, Cantor Fitzgerald restated an “overweight” rating and issued a $591.00 price objective on shares of UnitedHealth Group in a research note on Monday, August 19th. One research analyst has rated the stock with a hold rating, nineteen have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Buy” and a consensus price target of $614.17.

UnitedHealth Group Stock Performance

UnitedHealth Group stock opened at $597.64 on Friday. The stock has a 50-day simple moving average of $558.98 and a 200 day simple moving average of $515.15. The company has a quick ratio of 0.88, a current ratio of 0.88 and a debt-to-equity ratio of 0.67. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $607.94. The stock has a market capitalization of $551.87 billion, a price-to-earnings ratio of 36.53, a P/E/G ratio of 1.68 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share for the quarter, topping the consensus estimate of $6.66 by $0.14. The firm had revenue of $98.86 billion during the quarter, compared to analysts’ expectations of $98.73 billion. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The company’s quarterly revenue was up 6.4% compared to the same quarter last year. During the same period in the previous year, the business posted $6.14 EPS. On average, research analysts anticipate that UnitedHealth Group Incorporated will post 27.69 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th will be given a dividend of $2.10 per share. The ex-dividend date of this dividend is Monday, September 16th. This represents a $8.40 annualized dividend and a dividend yield of 1.41%. UnitedHealth Group’s payout ratio is currently 51.34%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.